KMC Speciality Hospitals (India) Ltd Hits New 52-Week High at Rs.86.85

Jan 05 2026 09:59 AM IST
share
Share Via
KMC Speciality Hospitals (India) Ltd reached a significant milestone on 5 Jan 2026, hitting a new 52-week high of Rs.86.85. This achievement underscores the stock’s strong momentum within the hospital sector, outperforming its peers and reflecting robust financial performance over the past year.



Stock Performance and Market Context


On the day of this milestone, KMC Speciality Hospitals recorded a day change of +0.96%, outperforming the hospital sector by 0.46%. Despite a slight pullback following two consecutive days of gains, the stock remains firmly above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning indicates sustained upward momentum and investor confidence in the company’s fundamentals.


In comparison, the broader market showed mixed signals. The Sensex opened lower at 85,640.05, down 121.96 points (-0.14%), and was trading marginally down by 0.06% at 85,710.08 during the same period. The Sensex itself is trading close to its own 52-week high of 86,159.02, just 0.52% away, supported by bullish moving averages where the 50-day DMA remains above the 200-day DMA. Notably, small-cap stocks led the market gains with the BSE Small Cap index rising by 0.14%, highlighting a broader appetite for growth-oriented stocks.



Financial Strength and Growth Drivers


KMC Speciality Hospitals has demonstrated solid financial health, which has been a key driver behind the stock’s rally. The company’s market capitalisation grade stands at 4, reflecting a mid-sized but steadily growing enterprise within the hospital sector. Its Mojo Score of 74.0 and upgraded Mojo Grade to ‘Buy’ from ‘Hold’ as of 23 Oct 2025 further affirm its improving quality and growth prospects.


Over the past year, the stock has delivered a total return of 11.04%, surpassing the Sensex’s 8.17% gain over the same period. This outperformance is supported by strong operational metrics. Operating profit has grown at an annualised rate of 31.48%, while net profit surged by 43.77%, with the company declaring very positive results in September 2025. The last two consecutive quarters have seen positive earnings results, reinforcing the company’s upward trajectory.




Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.



  • - New Reliable Performer

  • - Steady quarterly gains

  • - Fertilizers consistency


Discover the Steady Winner →




Balance Sheet and Valuation Metrics


The company’s balance sheet strength is evident in its low debt levels. The Debt to EBITDA ratio stands at a conservative 0.70 times, indicating a strong ability to service debt. The debt-equity ratio at half-year is notably low at 0.47 times, while the operating profit to interest coverage ratio is robust at 10.17 times, signalling comfortable interest servicing capacity.


Net sales for the latest quarter reached Rs.74.90 crores, reflecting a 22.3% increase compared to the previous four-quarter average. Return on Capital Employed (ROCE) is healthy at 20.3%, and the enterprise value to capital employed ratio is 6.1, suggesting a fair valuation relative to the company’s capital base. The stock currently trades at a discount compared to its peers’ average historical valuations, offering relative value within the hospital sector.



Technical and Trend Analysis


Technically, KMC Speciality Hospitals’ stock price has shown resilience and strength. Trading above all major moving averages confirms a bullish trend. The recent new 52-week high of Rs.86.85 marks a key resistance level breached, signalling positive momentum. Although the stock experienced a minor decline after two days of gains, this is typical profit-taking behaviour and does not detract from the overall upward trend.


The stock’s PEG ratio of 2.7 reflects a balance between growth and valuation, with profits rising by 17.1% over the past year. This ratio suggests that the stock’s price growth is broadly in line with its earnings growth, supporting the sustainability of the rally.




Curious about KMC Speciality Hospitals (India) Ltd from Hospital? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!



  • - Detailed research coverage

  • - Technical + fundamental view

  • - Decision-ready insights


Get the Complete Analysis →




Comparative Performance and Market Position


Over the last 52 weeks, the stock’s low was Rs.57, highlighting a substantial appreciation of over 52% to the current high of Rs.86.85. This performance is notable within the hospital sector, where growth is often steady but measured. KMC Speciality Hospitals’ ability to outperform the Sensex and sector averages reflects its operational efficiency and market positioning.


Despite the company’s size and growth, domestic mutual funds hold a minimal stake of just 0.01%. This limited exposure may reflect cautious positioning by institutional investors, though it does not diminish the company’s financial metrics or recent performance.



Summary of Key Metrics


To summarise, KMC Speciality Hospitals (India) Ltd’s recent new 52-week high of Rs.86.85 is supported by:



  • Strong annual net profit growth of 43.77%

  • Operating profit growth at 31.48% per annum

  • Low Debt to EBITDA ratio of 0.70 times and debt-equity ratio of 0.47 times

  • Robust operating profit to interest coverage ratio of 10.17 times

  • Healthy ROCE of 20.3% and fair valuation metrics

  • Outperformance relative to Sensex and sector indices


This combination of financial strength, operational growth, and technical momentum has propelled the stock to its current milestone, marking a noteworthy chapter in its market journey.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News